Inhibition of mutated, activated BRAF in metastatic melanoma.

Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB
N Engl J Med. 2010 363 (9): 809-19

PMID: 20818844 · PMCID: PMC3724529 · DOI:10.1056/NEJMoa1002011

MeSH Terms (19)

Adult Aged Aged, 80 and over Antineoplastic Agents Dose-Response Relationship, Drug Drug Resistance Drug Resistance, Neoplasm Female Humans Indoles Male Melanoma Middle Aged Mutation Proto-Oncogene Proteins B-raf Sulfonamides Treatment Outcome Vemurafenib Young Adult

Connections (2)

This publication is referenced by other Labnodes entities: